Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk of Breast Cancer”

705 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 705 results

Not applicableUnknownNCT00114296
What this trial is testing

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 80
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Not applicableStudy completedNCT05771454
What this trial is testing

Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives

Who this might be right for
Genetic PredispositionBRCA MutationBreast Cancer+1 more
Aga Khan University Hospital, Pakistan 26
Not applicableStudy completedNCT00001496
What this trial is testing

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

Who this might be right for
Breast NeoplasmHereditary Neoplastic Syndrome
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT00014222
What this trial is testing

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 2,104
Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00073073
What this trial is testing

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasms
Georgetown University 46
Testing effectiveness (Phase 2)Looking for participantsNCT06992336
What this trial is testing

Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411
Not applicableLooking for participantsNCT05245812
What this trial is testing

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

Who this might be right for
Breast CancerHigh Risk of Breast Cancer
Deborah Farr, MD 90
Not applicableUnknownNCT04789187
What this trial is testing

Exercise, Cancer and Cognition: The ECCO-Study

Who this might be right for
Breast Cancer
Johannes Kepler University of Linz 126
Not applicableLooking for participantsNCT06629896
What this trial is testing

Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial

Who this might be right for
Breast Cancer Screening and Diagnosis
Azienda USL Reggio Emilia - IRCCS 2,200
Not applicableUnknownNCT03618810
What this trial is testing

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

Who this might be right for
Febrile Neutropenia
Zhejiang Cancer Hospital 2,000
Testing effectiveness (Phase 2)Ended earlyNCT03387085
What this trial is testing

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

Who this might be right for
Triple Negative Breast Cancer
ImmunityBio, Inc. 9
Not applicableStudy completedNCT00996632
What this trial is testing

The Use of a High-frequency Ultrasonic Knife in Breast Cancer Surgery

Who this might be right for
Breast Cancer
University of Trieste 94
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05806385
What this trial is testing

Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

Who this might be right for
Triple Negative Breast Cancer
Texas Tech University Health Sciences Center 36
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Not applicableNot Yet RecruitingNCT06728150
What this trial is testing

Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticBrain Metastasases
Monash University 45
Not applicableWithdrawnNCT01409226
What this trial is testing

3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women

Who this might be right for
Breast CancerBRCA1 MutationBRCA2 Mutation
NYU Langone Health
Load More Results